| 1) Drug act on skins | ||||
| 1.1) Emollient and barrier preparations | ||||
| 1.2) Local anaesthetic and antipruritics | ||||
| 1.3) Topical Corticosteroids / Anti-infectives with Corticosteroids | ||||
| 1.4) Preparations for psoriasis and eczema | ||||
| 1.5) Preparations for Acne | ||||
| 1.6) Preparations for warts and Calluses | ||||
| 1.7) Shampoos and some other Scalp preparations | ||||
| 1.8) Anti-infective skin preparations | ||||
| 1.8.1) Antibacterial preparations | ||||
| 1.8.1.1) Antibacterial preparations only used topically | ||||
| 1.8.1.2) Antibacterial preparations also used systemically | ||||
| 1.8.2) Antifungal preparations | ||||
| 1.8.3) Anti-viral preparations | ||||
| 1.8.4) Parasiticidal Preparations | ||||
| 1.8.5) Preparations for minor skin infections | ||||
| 1.9) Disinfectants and Cleansers | ||||
| 1.9.1) Alcohols and Saline | ||||
| 1.9.2) Chlorhexidine Salts | ||||
| 1.9.3) Chlorine and Iodine | ||||
| 1.9.4) Astringents and oxidisers | ||||
| 1.9.5) Preparation for minor cuts and abrasions | ||||
| 1.10) Medicated Surgical Dressings | ||||
| 1.11) Others | ||||
| 2) Eye Preparations | ||||
| 2.1) Anti-infective Eye preparations | ||||
| 2.1.1) Antibacterials | ||||
| 2.1.2) Anti-virals | ||||
| 2.2) Corticosteroids / Anti-infectives with Corticosteroids | ||||
| 2.2.1) Anti-infectives with corticosteroids | ||||
| 2.2.2) Corticosteroids | ||||
| 2.3) Mydriatics and cycloplegics | ||||
| 2.4) Treatment of Glaucoma | ||||
| 2.5) Local Anesthetics | ||||
| 2.6) Miscellaneous Ophthalmic preparations | ||||
| 2.7) Others preparations | ||||
| 3.) Drug used in the treatment of disease of ear, nose and or opharynx | ||||
| 3.1) Drugs acting on the ear | ||||
| 3.1.1) Otitis Externa | ||||
| 3.1.2) Earwax Removal | ||||
| 3.2) Drugs actings on the Nose | ||||
| 3.2.1) Drugs used in nasal allergy | ||||
| 3.2.2) Topical Nasal decongestants | ||||
| 3.3) Drugs Acting on the oropharynx | ||||
| 3.3.1) Drugs for oral ulceration and inflammation | ||||
| 3.3.2) Oropharyngeal Anti-infective drugs | ||||
| 3.3.3) Lozenges | ||||
| 3.3.4) Mouth Wash | ||||
| 3.4) Other | ||||
| 4.) Drugs acting in the gastro-intestinal system | ||||
| 4.1) Antacids | ||||
| 4.1.1) Antacids with Aluminum only | ||||
| 4.1.2) Aluminum and Magnesium Containing Antacid | ||||
| 4.1.3) Sodium Bicarbonate | ||||
| 4.2) Antispasmodics and other drugs altering gut motility | ||||
| 4.3) Antiflatulent | ||||
| 4.4) Ulcer-healing Drugs | ||||
| 4.4.1) H2-receptor antagonists | ||||
| 4.4.2) Chelates and complexes | ||||
| 4.4.3) Prostaglandin Analogues | ||||
| 4.4.4) Proton Pump Inhibitors | ||||
| 4.5) Antidiarrhoeal Drugs | ||||
| 4.5.1) Adsorbents | ||||
| 4.5.2) Antimotility Drugs | ||||
| 4.5.3) Lactobacillis | ||||
| 4.6) Treatment of Chronic diarrhoeas | ||||
| 4.7) Laxatives | ||||
| 4.7.1) Stimulant Laxatives | ||||
| 4.7.2) Osmotic Laxatives | ||||
| 4.7.3) Bowel Cleansing solutions | ||||
| 4.7.4) Bulk-forming Agents | ||||
| 4.7.5) Others | ||||
| 4.8) Haemorrhoids, Phlebitis & Varicose Preparations | ||||
| 4.9) Drugs affecting intestinal secretions | ||||
| 4.9.1) Pancreatin | ||||
| 4.10) Cholagogues, cholelitholytics, and hepatic protectors | ||||
| 5) Drugs used in the treatment of disease of the cardiovascular system | ||||
| 5.1) Positive Inotropic Drugs | ||||
| 5.1.1) Cardiac Glycosides | ||||
| 5.2) Diuretics | ||||
| 5.2.1) Thiazides and Related Diuretics | ||||
| 5.2.2) Loop Diuretics | ||||
| 5.2.3) Potassium-sparing Diuretics | ||||
| 5.2.4)Potassium-sparing Diuretics with Other Diuretics | ||||
| 5.2.5) Osmotic diuretics | ||||
| 5.3) Anti-Arrhythmic Drugs | ||||
| 5.3.1) Supraventricular Arrhythmias | ||||
| 5.3.2) Supraventricular and Ventricular Arrhythmias | ||||
| 5.3.3) Ventricular Arrhythmias | ||||
| 5.4) Beta-Adrenoceptor Blocking Drugs | ||||
| 5.5) Antihypertensive Therapy | ||||
| 5.5.1) Vasodilator Antihypertensive Drugs | ||||
| 5.5.2) Centrally Acting Antihypertensive Drugs | ||||
| 5.5.3) Alpha-adrenoceptor Blocking Agents | ||||
| 5.5.4) Angiotensin-Converting Enzyme Inhibitors | ||||
| 5.5.5) Angiotensin-II Receptor Antagonists | ||||
| 5.6) Nitrates and Other Vasodilators and Calcium Channel Blockers | ||||
| 5.6.1) Nitrates | ||||
| 5.6.2) Calcium Channel Blockers | ||||
| 5.6.3) Peripheral Vasodilators and Related drugs | ||||
| 5.6.4) Cerebral Vasodilators | ||||
| 5.7) Sympathomimetics | ||||
| 5.7.1) Inotropic Sympathomimetics | ||||
| 5.7.2) Vasoconstrictor Sympathomimetics | ||||
| 5.7.3) Cardiopulmonary Resuscitation | ||||
| 5.8) Anticoagulants and Protamine | ||||
| 5.8.1) Parenteral Anticoagulants | ||||
| 5.8.2) Oral Anticoagulants | ||||
| 5.9) Anti-platelet Drugs | ||||
| 5.10) Fibrinolytic Drugs | ||||
| 5.11) Antifibrinolytic drugs and Haemostatics | ||||
| 5.12) Lipid Lowering drugs | ||||
| 6.) Drugs used in the treatment of disease of the respiratory system | ||||
| 6.1) Bronchodilators | ||||
| 6.1.1) Adrenoceptor Stimulants | ||||
| 6.1.1.1) Selective Beta-2 adrenoceptor stimulants | ||||
| 6.1.1.2) Others adrenoceptor stimulants | ||||
| 6.1.2) Anti-muscarinic bronchodilators | ||||
| 6.1.3) Theophylline | ||||
| 6.2) Corticosteroids | ||||
| 6.3) Cromoglycate and related therapy | ||||
| 6.4) Antihistamines and allergic Emergencies | ||||
| 6.4.1) antihistamines | ||||
| 6.4.1.1) Non-Sedative Antihistamines | ||||
| 6.4.1.2) Sedative Antihistamines | ||||
| 6.4.2) Allergic Emergencies | ||||
| 6.5) Respiratory Stimulants | ||||
| 6.6) Mucolytics | ||||
| 6.7) Antitussives | ||||
| 6.7.1) Cough Suppressants | ||||
| 6.7.2) Expectant, Demulcent, and compound cough preparations | ||||
| 6.7.3) Systemic nasal decongestants | ||||
| 7.) Drugs acting on the central Nervous system | ||||
| 7.1) Hypnotics and anxiolytics | ||||
| 7.1.1) Hypnotics | ||||
| 7.1.2) Anxiolytics | ||||
| 7.2) Drugs used in psychoses and related disorders | ||||
| 7.2.1) Antipsychotic Drugs | ||||
| 7.2.2) Antimanic drugs | ||||
| 7.3) Antidepressant Drugs | ||||
| 7.3.1) Tricyclic and related antidepressant drugs | ||||
| 7.3.2) Others Anti-depressant Drugs | ||||
| 7.4) Drugs used in nausea and vertigo | ||||
| 7.5) Analgesics and antipyretics | ||||
| 7.5.1) Non-opioid analgesics & Antipyretics | ||||
| 7.5.1.1) Compound analgesic preparation | ||||
| 7.5.2) Opioid analgesics | ||||
| 7.5.3) Trigeminal neuralgia | ||||
| 7.5.4) Antimigraine Drugs | ||||
| 7.5.4.1) Treatment of the acute migraine attack | ||||
| 7.5.4.2) Prophylaxis of migraine | ||||
| 7.6) Antiepileptics | ||||
| 7.6.1) Control of Epilepsy | ||||
| 7.6.2) Drugs used in Status Epilepticus | ||||
| 7.7) Drugs used in Parkinsonism and related disorders | ||||
| 7.7.1) Dopaminergic drugs used in parkinsonism | ||||
| 7.7.2) Antimuscarinic Drugs used in parkinsonism | ||||
| 7.7.3) Drugs used in Essential tremor, chorea, tics, and related disorder | ||||
| 7.8) Others | ||||
| 8) Drugs used in the treatment of infections | ||||
| 8.1) Antibacterial Drugs | ||||
| 8.1.1) Penicillins | ||||
| 8.1.1.1) Benzylpenicillin and phenoxymethylpenicillin | ||||
| 8.1.1.2) Penicillinase - Resistant Penicillins | ||||
| 8.1.1.3) Broad-Spectrum Penicillins | ||||
| 8.1.2) Cephalosporins and other Beta-Lactam Antibiotics | ||||
| 8.1.2.1) First Generation Cephalosporins | ||||
| 8.1.2.2) Second Generation Cephalosporins | ||||
| 8.1.2.3) Third Generation Cephalosporins | ||||
| 8.1.2.4) Others Beta-Lactam Antibiotics | ||||
| 8.1.3) Tetracyclines | ||||
| 8.1.4) Aminoglycosides | ||||
| 8.1.5) Macrolides | ||||
| 8.1.6) Clindamycin | ||||
| 8.1.7) Some other Antibiotics | ||||
| 8.1.8) Sulphonamides and Trimethoprim | ||||
| 8.1.9) Anti-tuberculous Drugs | ||||
| 8.1.10) Anti-leprotic Drugs | ||||
| 8.1.11) Metronidazole | ||||
| 8.1.12) 4-Quinolones | ||||
| 8.1.13) Urinary tract Infections | ||||
| 8.2) Antifungal Drugs | ||||
| 8.3) Anti-Viral Drugs | ||||
| 8.4) Anti-protozoal Drugs | ||||
| 8.4.1) Antimalarials | ||||
| 8.4.2) Amoebicides | ||||
| 8.5) Anthelmintics | ||||
| 8.5.1) Drugs for threadworms | ||||
| 8.5.2) Drugs for Ascaricides | ||||
| 8.5.3) Drugs for Schistosomicides, Liver flukes, Lung flukes | ||||
| 9.) Drugs used in the treatment of disorders of the endocrine systems | ||||
| 9.1) Drugs used in diabetes | ||||
| 9.1.1) Insulin | ||||
| 9.1.1.1) Short acting Insulin | ||||
| 9.1.1.2) Intermediate and long acting Insulin | ||||
| 9.1.2) Oral Anti-diabetic drugs | ||||
| 9.1.2.1) Sulphonylureas | ||||
| 9.1.2.2) Biguanides | ||||
| 9.1.2.3) Other | ||||
| 9.1.3) Treatment if Hypoglycaemia | ||||
| 9.1.4) Diagnostic and monitoring agents for diabetes mellitus | ||||
| 9.2) Thyroid and anti-thyroid drugs | ||||
| 9.2.1) Thyroid hormones | ||||
| 9.2.2) Antithyroid Drugs | ||||
| 9.3) Corticosteroids | ||||
| 9.3.1) Replacement therapy | ||||
| 9.4) Sex hormones | ||||
| 9.4.1) Female Sex hormones | ||||
| 9.4.1.1) Oestrogens and hormone replacement therapy | ||||
| 9.4.1.2) Progestogens | ||||
| 9.4.2) Male sex hormones and antagonists | ||||
| 9.4.3) Anabolic Steroid | ||||
| 9.5) Hypothalamic and pituitary hormones and anti-oestrogens | ||||
| 9.5.1) Hypothalamic and anterior pituitary hormones and anti-oestrogens | ||||
| 9.5.2) Posterior pituitary hormones and antagonists | ||||
| 9.6) Drugs Affecting bone metabolism | ||||
| 9.6.1) Calcitonin | ||||
| 9.6.2) Bisphosphonates | ||||
| 9.7) Other Endocrine Drugs | ||||
| 9.7.1) Bromocriptine | ||||
| 9.7.2) Danazol and Gonadorelin Analogues | ||||
| 9.8) Malignant Disease and Immunosuppression | ||||
| 9.8.1) Cytotoxic antibiotic | ||||
| 9.8.2) Antimetabolites | ||||
| 9.9) Sex Hormones and hormone antagonists in Malignant Disease | ||||
| 9.9.1) Progestogens | ||||
| 9.9.2) Oestrogen | ||||
| 9.9.3) Hormone Antagonist | ||||
| 9.9.3.1) Breast Cancer | ||||
| 9.9.3.2) Prostate cancer and Gonadorelin Analogues | ||||
| 9.9.3.3) Somatostatin Analogues | ||||
| 10.) Drugs used in obstetrics, gynaecology and urinary-tract disorders | ||||
| 10.1) Drugs used in obstetrics | ||||
| 10.1.1) Prostaglandins and oxytocics | ||||
| 10.1.2) Myometrial Relaxants | ||||
| 10.1.3) Others | ||||
| 10.2) Treatment of vaginal and vulval conditions | ||||
| 10.2.1) Topical Hormones | ||||
| 10.2.2) Anti-Infective drugs (genital antifungal preparations) | ||||
| 10.3) Contraceptives | ||||
| 10.3.1) Combined oral contraceptives | ||||
| 10.3.2) Parenteral Contraceptives | ||||
| 10.4) Drugs for genito-urinary disorders | ||||
| 10.4.1) Drugs for urinary Retention | ||||
| 10.4.2) Drugs for Urinary frequency, Enuresis and incontinence | ||||
| 10.4.3) Drugs used in Urological pain | ||||
| 10.4.3.1) Alkalinisation of Urine | ||||
| 10.4.3.2) Acidification of Urine | ||||
| 10.4.3.3) Others preparations for urinary disorders | ||||
| 10.4.4) Bladder Instillations and urological surgery | ||||
| 10.4.5) Drugs for impotence | ||||
| 11.) Drugs used in the treatment of musculoskeletal and joint diseases | ||||
| 11.1) Drugs used in rheumatic diseases and gout | ||||
| 11.1.1) Non-steroidal anti-inflammatory Drugs (NSAIDs) | ||||
| 11.1.2) Corticosteroids | ||||
| 11.1.3) Drugs which suppress the rheumatic disease process | ||||
| 11.1.4) Drugs used in the treatment of gout | ||||
| 11.2) Drugs used in neuromuscular disorders | ||||
| 11.2.1) Drugs which enhance neuromuscular transmission | ||||
| 11.2.2) Skeletal muscle relaxants | ||||
| 11.3) Drugs for the relief of soft-tissue inflammation | ||||
| 11.3.1) Enzymes | ||||
| 11.3.2) Rubefacients and other topical Anti-rheumatics | ||||
| 11.4) Others | ||||
| 12. Immunological products and Vaccines | ||||
| 12.1) Vaccines and Antisera | ||||
| 12.2) Immunogloblins | ||||
| 13. Drugs used in Anaesthesia | ||||
| 13.1) General anaesthesia | ||||
| 13.1.1) Intravenous anaesthetics | ||||
| 13.1.2) Inhalational Anaesthetics | ||||
| 13.1.3) Antimuscarinic premedication drugs | ||||
| 13.1.4) Sedative and analgesic peri-operative drugs | ||||
| 13.1.4.1) Anxiolytics and Neuroleptics | ||||
| 13.1.4.2) Non-Steroidal Anti-Inflammatory drugs (See Section 11.1.1) | ||||
| 13.1.4.3) Opioid Analgesics | ||||
| 13.1.5) Muscle Relaxants | ||||
| 13.1.6) Anti-cholinesterases used in Surgery | ||||
| 13.1.7) Antagonists for Central and Respiratory Depression | ||||
| 13.1.8) Drugs for Malignant Hyperthermia | ||||
| 13.2) Local Anaesthesia | ||||
| 14.) Drugs Affecting Nutrition and Blood | ||||
| 14.1) Anaemias and some other blood disorders | ||||
| 14.1.1) Iron-deficiency anaemias | ||||
| 14.1.2) Drugs used in Megaloblastic anaemias | ||||
| 14.1.3) Erythropoietin | ||||
| 14.2) Fluids and Electrolytes | ||||
| 14.2.1) Oral Administration | ||||
| 14.2.1.1) Oral Potassium | ||||
| 14.2.1.2) Oral Sodium | ||||
| 14.2.1.3) Oral Bicarbonate | ||||
| 14.2.2) Intravenous Administration | ||||
| 14.2.3) Plasma and Plasma Substitutes | ||||
| 14.3) Intravenous Nutrition | ||||
| 14.4) Oral Nutrition | ||||
| 14.5) Minerals | ||||
| 14.5.1) Calcium | ||||
| 14.5.2) Phosphate-binding agents | ||||
| 14.6) Vitamins | ||||
| 14.6.2) Vitamin C | ||||
| 14.6.3) Vitamin D | ||||
| 14.6.4) Vitamin E | ||||
| 14.6.5) Vitamin K | ||||
| 14.6.6) Multivitamin Preparations | ||||
| 15.) Drugs Used in Emergency Treatment of Poisoning | ||||
| 15.1) Removal and Elimination | ||||
| 15.1.1) Removal from the stomach | ||||
| 15.1.2) Prevention of Absorption | ||||
| 15.1.3) Opioid Poisoning | ||||
| 16. Miscellaneous | ||||
¡@